Aflibercept, bevacizumab, and ranibizumab all improve vision in eyes with center-involved diabetic macular edema, according to a randomized clinical trial. The relative effect of the three drugs ...

The Diabetic Retinopathy Clinical Research Network (DRCR.net) conducted a comparative effectiveness trial evaluating the prevalence of persistent diabetic macular edema (DME) and its effect on visual ...